http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012227280-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a2f3e49ef6b2201d6b700eeaa04ce39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate | 2012-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a403c0c8dcde7e799bdb6615855adb8 |
| publicationDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2012227280-B2 |
| titleOfInvention | Human cytomegalovirus immunotherapy |
| abstract | An isolated protein construct comprises a polyepitope derived from multiple human cytomegalovirus protein antigen epitopes conjugated to an extracellular domain of glycoprotein B, which isolated protein is capable of eliciting a cytotoxic T 5 lymphocyte immune response as well as a neutralizing antibody response to human cytomegalovirus. Also provided are pharmaceutical compositions comprising the isolated protein or an adenoviral expression construct for delivery and expression of a nucleic acid encoding the isolated protein for prophylactic and/or therapeutic treatment of human cytomegalovirus infection, particularly in humans. 14 I P4H P4 CLV) 1~4i-1 c oo 0 C,) 0 >I Dhus~Of > Cy ca r34 a.( rN Cy p H0C -0 E-.C P, , H 0.o H *0 w. 1 0 . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017203370-A3 |
| priorityDate | 2004-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 183.